Search Results - "McDonald, Susan A."

Refine Results
  1. 1

    Gastric Stasis in Migraine: More Than Just a Paroxysmal Abnormality During a Migraine Attack by Aurora, Sheena K., Kori, Shashidhar H., Barrodale, Pat, McDonald, Susan A., Haseley, David

    Published in Headache (01-01-2006)
    “…Objective.—The aim of this article is to evaluate gastric motility and emptying in the ictal and interictal period in migraine. Background.—Nausea is a…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Fixed-dose sumatriptan/naproxen sodium compared with each monotherapy utilizing the novel composite endpoint of sustained pain-free/no adverse events by Landy, Stephen, White, Jonathan, Lener, Shelly E., McDonald, Susan A.

    “…A novel composite endpoint, sustained pain-free/no adverse events, was recently proposed as a more rigorous means of capturing in a single measure the…”
    Get full text
    Journal Article
  4. 4

    Combination Treatment for Menstrual Migraine and Dysmenorrhea Using Sumatriptan–Naproxen: Two Randomized Controlled Trials by Mannix, Lisa K., Martin, Vincent T., Cady, Roger K., Diamond, Merle L., Lener, Shelly E., White, Jonathan D., Derosier, Frederick J., McDonald, Susan A.

    Published in Obstetrics and gynecology (New York. 1953) (01-07-2009)
    “…To evaluate the efficacy and tolerability of sumatriptan-naproxen during the mild pain phase of a single menstrual migraine attack associated with…”
    Get full text
    Journal Article
  5. 5

    Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium by Martin, Vincent T, Ballard, Jeanne, Diamond, Michael P, Mannix, Lisa K, Derosier, Frederick J, Lener, Shelly E, Krishen, Alok, McDonald, Susan A

    “…Dysmenorrhea and menstrual migraine may share a common pathogenic pathway. Both appear to be mediated, in part, by an excess of prostaglandin production that…”
    Get more information
    Journal Article
  6. 6

    Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: a randomized study by Silberstein, Stephen, McDonald, Susan A, Goldstein, Jerome, Aurora, Sheena, Lener, Shelly E, White, Jonathan, Runken, Michael C, Saiers, Jane, Derosier, Frederick, Lipton, Richard B

    Published in Cephalalgia (01-04-2014)
    “…Probable migraine is a common, disabling migraine subtype fulfilling all but one of the diagnostic criteria for migraine. This study was conducted to evaluate…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Revisiting the Efficacy of Sumatriptan Therapy During the Aura Phase of Migraine by Aurora, Sheena K., Barrodale, Patricia M., McDonald, Susan A., Jakubowski, Moshe, Burstein, Rami

    Published in Headache (01-07-2009)
    “…Objective.— To reexamine the efficacy of terminating migraine headache by administration of sumatriptan during the visual‐aura phase of the attack…”
    Get full text
    Journal Article
  9. 9

    Long-Term Evaluation of Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents by McDonald, Susan A., Hershey, Andrew D., Pearlman, Eric, Lewis, Donald, Winner, Paul K., Rothner, David, Linder, Steven L., Runken, M. Chris, Richard, Nathalie E., Derosier, Frederick J.

    Published in Headache (01-10-2011)
    “…Objectives.— To evaluate the long‐term safety, tolerability, effectiveness, impact on quality of life, and medication satisfaction of sumatriptan/naproxen…”
    Get full text
    Journal Article
  10. 10

    Distinct Pharmacokinetic Profile and Safety of a Fixed-Dose Tablet of Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine by Haberer, Lynda J., Walls, Christine M., Lener, Shelly E., Taylor, David R., McDonald, Susan A.

    Published in Headache (01-03-2010)
    “…(Headache 2010;50:357‐373) Objective.— To describe the pharmacokinetic and safety profiles of sumatriptan 85 mg formulated with RT Technology (RT) and naproxen…”
    Get full text
    Journal Article
  11. 11

    Sumatriptan-Naproxen Sodium for Menstrual Migraine and Dysmenorrhea: Satisfaction, Productivity, and Functional Disability Outcomes by Cady, Roger K., Diamond, Merle L., Diamond, Michael P., Ballard, Jeanne E., Lener, Michelle E., Dorner, Deborah P., Derosier, Frederick J., McDonald, Susan A., White, Jonathan, Runken, M. Chris

    Published in Headache (01-05-2011)
    “…(Headache 2011;51:664‐673) Objective.— To evaluate the impact of a sumatriptan/naproxen sodium combination tablet on patient satisfaction, productivity, and…”
    Get full text
    Journal Article
  12. 12

    Clarification of Developing and Established Clinical Allodynia and Pain-Free Outcomes by Landy, Stephen H., McGinnis, Judy E., McDonald, Susan A.

    Published in Headache (01-02-2007)
    “…Objective.—The aim of this study was to determine whether clinical indicators of cutaneous allodynia predict the success of migraine therapy with sumatriptan…”
    Get full text
    Journal Article
  13. 13

    Pilot Study Evaluating Preference for 3-mg Versus 6-mg Subcutaneous Sumatriptan by Landy, Stephen H., McGinnis, Judy E., McDonald, Susan A.

    Published in Headache (01-04-2005)
    “…Background.—Subcutaneous sumatriptan (6 mg) is undeniably an excellent treatment of migraine. However, some patients have avoided using 6 mg sumatriptan…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Clinical effects of methamphetamine vapor inhalation by Perez-Reyes, M, White, W R, McDonald, S A, Hill, J M, Jeffcoat, A R, Cook, C E

    Published in Life sciences (1973) (1991)
    “…Despite the increasing popularity of crystalline methamphetamine ("ice") vapor inhalation, no investigations have reported drug plasma concentrations and…”
    Get more information
    Journal Article
  16. 16

    Clinical effects of daily methamphetamine administration by Perez-Reyes, M, White, W R, McDonald, S A, Hicks, R E, Jeffcoat, A R, Hill, J M, Cook, C E

    Published in Clinical neuropharmacology (01-08-1991)
    “…This study investigated alterations in the disposition and pharmacodynamics of methamphetamine HCl after daily administration. Six male paid volunteers…”
    Get more information
    Journal Article
  17. 17

    SumatriptanaNaproxen Sodium for Menstrual Migraine and Dysmenorrhea: Satisfaction, Productivity, and Functional Disability Outcomes by Cady, Roger K, Diamond, Merle L, Diamond, Michael P, Ballard, Jeanne E, Lener, Michelle E, Dorner, Deborah P, Derosier, Frederick J, McDonald, Susan A, White, Jonathan, Runken, MChris

    Published in Headache (01-05-2011)
    “…Objective.- To evaluate the impact of a sumatriptan/naproxen sodium combination tablet on patient satisfaction, productivity, and functional disability in…”
    Get full text
    Journal Article
  18. 18

    Self-Reported Medication Adherence and Health Status in Late Adulthood: The Role of Beliefs by McDonald-Miszczak, L, Maki, S A, Gould, O N

    Published in Experimental aging research (01-07-2000)
    “…In this study, we explore the role of subjective beliefs in determining self-reports of medication adherence and health status in 90 older adults (M age = 71.7…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Brief Communications: Pilot Study Evaluating Preference for 3-mg Versus 6-mg Subcutaneous Sumatriptan by Landy, Stephen H, McGinnis, Judy E, McDonald, Susan A

    Published in Headache (01-04-2005)
    “…Background.-Subcutaneous sumatriptan (6 mg) is undeniably an excellent treatment of migraine. However, some patients have avoided using 6 mg sumatriptan…”
    Get full text
    Journal Article